MM accounts for 0.8% of new cancer cases and 0.9% of cancer death worldwide [45] and is defined by malignant transformation of PC that usually overproduce large quantities of an aberrant monoclonal immunoglobulin fragment, the M protein. The gene discussed is MYOM2; the disease is Miyoshi myopathy.